Saxo Spotlight: What’s on investors and traders radars this week?
Macro

Saxo Spotlight: What’s on investors and traders radars this week?

APAC Strategy Team

Summary:  There are some big macro worries as we enter the final quarter of the year. We are looking at not just how the UK crisis could develop further, but also which other country/market could succumb to the US yields or dollar strength as market disruptions are likely to widen. Geopolitics also remains a key focus amid Putin’s military losses, as this could mean he could further try to choke Europe and the world of key supplies. A significant production cut from OPEC+ is already making headlines, but China markets are away for the Golden Week. Reserve Bank of Australia may need to delay slowing down its pace of rate hikes, and brace for more profit warnings as well ahead of the Q3 earnings season which goes into full swing in two weeks.

US ISM indices and payrolls data to continue the economic optimism, spurring risk off in the markets

As the US economy continues to stay strong despite the aggressive Fed tightening, markets continue to be beaten out. Some respite was seen in the US yields and the US dollar last week, but data due this week could bring further risk-off with markets starting to price out some rate hike expectations for next year with the risks emerging from crisis in UK and possibly more crisis coming due to the run higher in US yields and USD. Data will likely show continued strength in the US economy and labor markets, especially ahead of the midterm elections. ISM manufacturing for September is due in the US session today, and Bloomberg consensus estimates signal some signs of a slowdown to 52.1 in September from 52.8 in August – that should likely be underpinned by improving supply chains, while new orders should remain upbeat and keep the sentiment positive. ISM services follows on Wednesday, and may also moderate as the services sector cools down from a peak, but will stay robust. Finally, the payrolls data on Friday is set for another positive surprise after sub-200k weekly jobless claims last week. Bloomberg consensus estimate as of now stand at gains of 250k for September from 315k last month, with unemployment rate and average hourly earnings steady at 3.7% and 0.3% respectively.

Russia’s counter-attack risks

Less than a day after Russia’s annexation of four Ukrainian cities and claims for these to be Russian territory, parts of these cities have been recaptured by Ukraine over the weekend. That is another military setback for Russia, and would possibly mean that Putin would be keen to press Europe’s energy nerves further as winter demand for energy starts to flow in. There are two key risks to highlight here: 1) Russia could cut supplies from Ukraine as well further to choke Europe and the world of energy and food supplies; and 2) there is an imminent threat of use of some low-yield nuclear weapons given how desperate Russia is now. Any of these moves could spur further risk off in the markets this week, and potentially, the effect will spill over to energy and agriculture markets, so think oil, gas, wheat, soybeans and the likes.

OPEC+ meeting on October 5 may bring production cuts

Oil prices were supported at the end of last week amid hopes of a production cut by OPEC+ members at their meeting this week. There were some reports that OPEC members have started talking about cuts with Russia proposing a 1 mln barrels per day cut, a reduction towards which they are unlikely to contribute much as they are already producing below their quota. At its last meeting on September 5, the group agreed a token reduction of 100,000 barrels a day for October, despite calls from consuming nations to help tame rampant inflation by keeping the taps open. With gasoline prices retreating in the US, some of that external pressure may now be easing, and that further raises the prospects of some price-supportive action.

Reserve Bank of Australia may step away from moving to a slower rate hike pace

The Reserve Bank of Australia is scheduled to announce its next rate decision on Tuesday, October 4. Governor Lowe had previously signalled that the pace of rate hikes is likely to slow from here after four consecutive rate hikes of the magnitude of 50bps. However, money markets and Bloomberg consensus forecast is still calling for another 50bps rate hike at the October meeting suggesting that RBA may delay taking the foot off the pedal just yet. The recent slide in the Australian dollar and worries over a turmoil in global financial markets may prompt the policymakers to front-load more of the rate hikes while the economy is still holding up. Retail sales data last week was upbeat while the first monthly inflation data reading at 6.8% is only slightly off the 7% levels seen in the preceding month. So, even as a monthly meeting can ensure a steady pace of rate hikes even with a smaller 25bps rate move, policymakers would possibly prefer to make a larger move this week to provide some support to the AUD. Likewise, the Reserve Bank of New Zealand is also expected to hike rates by another 50bps at their October 6 meeting.

Japan’s Tokyo CPI to see impact of reopening

Japan’s inflationary pressures are likely to continue to reign amid higher global prices of food, electricity as well as a weak yen propping up import prices. Bloomberg consensus estimates point to a slightly softer headline print of 2.7% YoY from 2.9% YoY previously, but the core is pinned higher at 2.8% YoY from 2.6% YoY previously. Further, the reopening of the economic from the pandemic curbs likely means demand side pressures are also broadening, and services inflation will potentially pick up as well.

Slow earnings week but watch for further profit warnings ahead of the Q3 reporting season

Last week, Biogen and its Japanese partner Eisai announced positive results in a phase-3 study on a treatment that slows Alzheimer’s disease. Analysts are eager to learn more about the treatment from the company’s presentation of more data at the Clinical Trails on Alzheimer’s Disease conference on Nov 29. For Q3 results, analysts expect Biogen’s revenue and adj. EPS to fall by around 11% to 12% Y/Y.

Analysts are expecting beverage company, Constellation Brands’ (STZ:xnys) revenues to grow at 5.6% Y/Y in the quarter ending Aug 31, led by its core bear portfolio of Modelo Especial and Corona Extra which recent channel surveys from Beverage Bytes and Nielsen suggested outperformance. The consensus estimate is optimistic and anticipates over 18% Y/Y growth on Adj. EPS with margin expansion.

Tesco’s (TSCO:xlon) FY23 1H results (ending Aug 31), scheduled to release this week, are worth watching it can let us have a glimpse of the state of U.K. consumers and some insights into the latest development in the inflation in the U.K. Analysts are expecting the U.K. grocer to report margin compression as a result of high energy costs and wage increases. 

 

Key economic releases & central bank meetings this week

Monday, Oct 3

Japan Tankan survey (Q3)
ISM US manufacturing survey (Sep)
Indonesia inflation (Sep)

Tuesday, Oct 4

Australia home loans, building permits (Aug)
Australia RBA policy decision
Eurozone PPI (Aug)
US factory orders, JOLTS (Aug)

Wednesday, Oct 5

ISM US non-manufacturing survey (Sep)
S Korea inflation (Sep)
New Zealand RBNZ policy decision
P
hilippines inflation (Sep)
Thailand inflation (Sep)
Australia retail sales (Aug)
Germany trade balance (Aug)
ECB non-monetary policy meeting
US MBA mortgage applications/30-year mortgage rate
US trade balance (Aug), ADP employment (Sep)
Canada trade balance, building permits (Aug)

Thursday, Oct 6

Australia trade balance (Aug)
Taiwan inflation (Sep)
Germany factory orders (Aug)
UK & eurozone construction PMIs (Sep)
Eurozone retail sales (Aug)
US jobless claims

Friday, Oct 7

Japan household spending (Aug)
Germany industrial production (Aug)
UK Halifax house prices (Sep)
Canada labour market statistics (Sep)
US employment report (Sep)
US consumer credit, wholesale inventories (Aug)

 

Key earnings releases this week

  • Tuesday: Biogen
  • Wednesday: Keurig Dr Pepper, Aeon, Lamb Weston, Tesco, RPM International
  • Thursday: Seven & I, Conagra Brands, Constellation Brands, McCormick & Co
Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)
- Full disclaimer (https://www.home.saxo/en-mena/legal/disclaimer/saxo-disclaimer)


Boulevard Plaza, Tower 1, 30th floor, office 3002
Downtown, P.O. Box 33641 Dubai, UAE

Contact Saxo

Select region

UAE
UAE

Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

Saxo Bank A/S is licensed by the Danish Financial Supervisory Authority and operates in the UAE under a representative office license issued by the Central bank of the UAE.

The content and material made available on this website and the linked sites are provided by Saxo Bank A/S. It is the sole responsibility of the recipient to ascertain the terms of and comply with any local laws or regulation to which they are subject.

The UAE Representative Office of Saxo Bank A/S markets the Saxo Bank A/S trading platform and the products offered by Saxo Bank A/S.